TMSB4XP2: A Potential Drug Target and Biomarker (G7116)

Target Name: TMSB4XP2

NCBI ID: G7116

TMSB4XP2

Other Name(s): TMSL2 | Thymosin beta 4, X-linked pseudogene 2 | TMSB4X pseudogene 2

TMSB4XP2: A Potential Drug Target and Biomarker

Tissue factor (TF) dependent intracellular signaling pathways have been implicated in a wide range of physiological processes, including hemostasis, angiogenesis, and cancer progression. Tissue factor (TF) dependent intracellular signaling pathways have also been implicated in the development and progression of various diseases, including cancer. The protein TMSB4XP2 (TMSL2), which is located on the surface of certain immune cells, has been identified as a potential drug target and biomarker for several diseases, including cancer.

TMSB4XP2 is a member of the TMSB4 family, which is characterized by the presence of a unique transmembrane domain and a short cytoplasmic tail. TMSB4XP2 is expressed in various tissues and cells, including immune cells, where it is involved in the regulation of cellular processes such as cell adhesion, migration, and survival.

One of the most significant functions of TMSB4XP2 is its role in the regulation of the cytoskeleton. TMSB4XP2 is involved in the formation and maintenance of the cytoskeleton, which is responsible for the structural integrity of cells and plays a crucial role in the regulation of cellular processes such as cell division, migration, and intracellular signaling pathways.

In addition to its role in the regulation of the cytoskeleton, TMSB4XP2 is also involved in the regulation of cell adhesion and migration. TMSB4XP2 has been shown to play a role in the regulation of cell adhesion by interacting with cell adhesion molecules such as cadherins and immunoglobulin-like cell adhesion molecules (Ig-CAMs). TMSB4XP2 has also been shown to play a role in the regulation of cell migration by interacting with factors such as the transcription factor, NF-kappa-B, and the protein, T-cell factor (TGF-1).

TMSB4XP2 is also involved in the regulation of cellular signaling pathways. TMSB4XP2 has been shown to play a role in the regulation of several intracellular signaling pathways, including the TGF-1 signaling pathway. TMSB4XP2 has been shown to interact with the transcription factor, SMAD1, and to regulate the activity of the transcription factor, NF-kappa-B. TMSB4XP2 has also been shown to play a role in the regulation of the signaling pathway between the transcription factor, NF-kappa-B, and the protein, p53.

In addition to its role in the regulation of intracellular signaling pathways, TMSB4XP2 is also involved in the regulation of cellular responses to stimuli. TMSB4XP2 has been shown to play a role in the regulation of cellular responses to stimuli by interacting with the protein, PDGF-1. TMSB4XP2 has also been shown to regulate the activity of the protein, FGF-1, which is involved in the regulation of cellular responses to stimuli.

TMSB4XP2 is also involved in the regulation of cellular processes such as cell growth and apoptosis. TMSB4XP2 has been shown to play a role in the regulation of cell growth by interacting with the transcription factor, EGFR. TMSB4XP2 has also been shown to play a role in the regulation of apoptosis by interacting with the protein, Bcl-2.

In conclusion, TMSB4XP2 is a protein that is involved in the regulation of a wide range of cellular processes, including

Protein Name: TMSB4X Pseudogene 2

The "TMSB4XP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMSB4XP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets